Ascendis Pharma A reported a gross margin of 91.85% and a net margin of 1.43% for the quarter ended Jun 2026. These financial ratios cover 51 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 100.00% | 1.60% | 37.81% | 82.37% | 88.93% | 77.68% | 86.24% | 72.72% | 84.62% | 85.87% | 92.11% | 68.15% | 80.63% | 91.94% | 82.65% | 80.10% | 89.54% | 90.47% | 92.90% | 91.85% | |||||||||||||||||||||||||||||||
| EBT Margin | -7,218.60% | -123.27% | -1,834.46% | -1,320.88% | -1,106.10% | -882.60% | -326.35% | -257.13% | -336.38% | -58.89% | -134.03% | -303.21% | -169.76% | -21.50% | -92.68% | -22.15% | -26.86% | -10.79% | -19.54% | 67.82% | |||||||||||||||||||||||||||||||
| EBIT Margin | -8,709.07% | -130.71% | -1,875.06% | -2,303.46% | -945.09% | -643.75% | -427.77% | -297.17% | -279.82% | -26.59% | -51.25% | -370.18% | -167.28% | 0.22% | -103.23% | -33.50% | 5.15% | 4.00% | 10.06% | 64.98% | |||||||||||||||||||||||||||||||
| EBITDA Margin | -8,709.07% | -113.36% | -1,875.06% | -2,303.46% | -945.09% | -567.25% | -427.77% | -297.17% | -279.82% | -23.49% | -51.25% | -370.18% | -167.28% | 3.05% | -101.30% | -33.50% | 5.15% | 6.47% | 10.63% | 64.98% | |||||||||||||||||||||||||||||||
| Operating Margin | -8,709.07% | -130.71% | -1,875.06% | -2,303.46% | -945.09% | -643.75% | -427.77% | -297.17% | -279.82% | -26.59% | -51.25% | -370.18% | -167.28% | 0.22% | -103.23% | -33.50% | 5.15% | 4.00% | 10.06% | 64.98% | |||||||||||||||||||||||||||||||
| Net Margin | 91.28% | -448.58% | 6.22% | -12.29% | -14.43% | 9.66% | -2.34% | -2.14% | 1.19% | -1.09% | 0.07% | 0.04% | 0.27% | 0.48% | -0.07% | -0.89% | -0.74% | -13.56% | 1.24% | 1.43% | |||||||||||||||||||||||||||||||
| FCF Margin | -7,746.54% | -137.60% | -1,859.55% | -1,958.88% | -625.70% | -602.33% | -434.54% | -322.17% | -257.62% | -30.89% | -105.72% | -169.36% | -96.25% | -50.13% | -14.18% | -4.64% | 1.01% | -42.94% | -3.13% | 83.02% | |||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.08B | 0.10B | 0.11B | 0.11B | 0.12B | 0.15B | 0.17B | 0.19B | 0.22B | 0.24B | 0.26B | 0.28B | 0.30B | 0.31B | 0.33B | 0.35B | 0.35B | 0.36B | 0.36B | ||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 1.22B | 1.85B | 1.92B | 1.48B | 1.35B | 1.20B | 1.07B | 0.97B | 0.92B | 0.92B | 0.88B | 0.84B | 1.01B | 2.28B | 2.24B | 1.17B | 1.29B | 1.43B | 1.93B | 2.50B | |||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 1.13B | 1.44B | 1.29B | 1.13B | 0.83B | 0.82B | 0.69B | 0.62B | 0.24B | 0.21B | 0.06B | 0.45B | 0.44B | 0.36B | 0.37B | 0.46B | 0.56B | 1.36B | 2.12B | ||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.07 | 0.06 | 0.06 | 0.08 | 0.09 | 0.04 | 0.08 | 0.13 | 0.18 | 0.31 | 0.40 | 0.41 | 0.35 | 0.17 | 0.18 | 0.46 | 0.56 | 0.57 | 0.52 | 0.49 | |||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -110.53 | 287.93 | -23.71 | -15.04 | -3.50 | -5.87 | -14.60 | -15.09 | -5.48 | -0.57 | -0.64 | -6.79 | 3.82 | -0.01 | 2.33 | 1.60 | -0.16 | -0.16 | -0.37 | -15.56 | |||||||||||||||||||||||||||||||
| Debt Ratio | 0.05 | 0.44 | 0.45 | 0.52 | 0.50 | 0.62 | 0.69 | 0.74 | 0.44 | 0.53 | 0.50 | 0.46 | 0.16 | 0.50 | 0.48 | 0.49 | 0.49 | 0.34 | 0.17 | ||||||||||||||||||||||||||||||||
| Times Interest Earned | -110.53 | 287.93 | -23.71 | -15.04 | -3.50 | -5.87 | -14.60 | -15.09 | -5.48 | -0.57 | -0.64 | -6.79 | 3.82 | -0.01 | 2.33 | 1.60 | -0.16 | -0.16 | -0.37 | -15.56 | |||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 0.00B | -17.33 | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -338.29 | 0.00B | 0.00B | |||||||||||||||||||||||||||||||
| Price to SalesP/S | 0.00B | 77.74 | 871.97 | 805.24 | 381.37 | 298.82 | 169.97 | 98.84 | 102.35 | 49.06 | 83.74 | 203.02 | 135.66 | 44.96 | 89.08 | 58.55 | 48.31 | 45.87 | 49.10 | 41.92 | |||||||||||||||||||||||||||||||
| Price to BookP/B | 7.31 | 7.58 | 8.85 | 8.16 | 12.91 | 25.98 | 34.15 | 72.24 | -66.95 | -46.37 | -33.71 | -22.76 | -80.62 | -73.97 | -47.38 | -49.34 | -59.29 | -69.73 | 24.81 | 9.90 | |||||||||||||||||||||||||||||||
| Enterprise Value | 7.67B | 7.14B | 5.74B | 4.53B | 5.25B | 6.51B | 5.59B | 4.67B | 4.87B | 6.84B | 8.38B | 7.59B | 7.93B | 6.98B | 8.30B | 9.23B | 10.64B | 12.50B | 13.51B | 15.59B | |||||||||||||||||||||||||||||||
| EV to EBIT | -67.06 | -55.47 | -39.93 | -29.94 | -36.04 | -43.29 | -36.25 | -30.46 | -33.29 | -173.61 | -156.88 | -52.90 | -74.63 | 0.00B | -75.69 | -153.98 | 827.88 | 0.00B | 464.93 | 60.82 | |||||||||||||||||||||||||||||||
| EV to EBITDA | -67.06 | -63.96 | -39.93 | -29.94 | -36.04 | -49.12 | -36.25 | -30.46 | -33.29 | -196.51 | -156.88 | -52.90 | -74.63 | 0.00B | -77.13 | -153.98 | 827.88 | 670.59 | 439.86 | 60.82 | |||||||||||||||||||||||||||||||
| Market Capitalization | 8.57B | 7.66B | 6.68B | 5.29B | 5.88B | 6.98B | 6.13B | 5.10B | 5.35B | 7.27B | 8.72B | 7.87B | 8.62B | 8.36B | 9.46B | 10.48B | 12.07B | 13.22B | 14.18B | 16.53B | |||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -84.26 | -56.50 | -46.89 | -41.11 | -60.95 | -49.61 | -39.11 | -30.68 | -39.73 | -158.82 | -79.21 | -119.87 | -140.95 | -89.69 | -628.27 | -0.00B | 0.00B | -106.84 | -0.00B | 50.49 | |||||||||||||||||||||||||||||||
| EV to FCF | -75.39 | -52.69 | -40.26 | -35.21 | -54.43 | -46.26 | -35.68 | -28.10 | -36.16 | -149.43 | -76.05 | -115.63 | -129.71 | -74.93 | -551.12 | -0.00B | 0.00B | -101.04 | -0.00B | 47.60 | |||||||||||||||||||||||||||||||
| EV to CFO | -66.66 | -50.64 | -39.08 | -34.15 | -52.69 | -45.03 | -35.42 | -28.02 | -35.88 | -149.65 | -75.90 | -114.99 | -128.63 | -74.93 | -551.12 | -0.00B | 0.00B | -101.04 | -0.00B | 47.60 | |||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -8,709.07% | -130.71% | -1,875.06% | -2,303.46% | -945.09% | -643.75% | -427.77% | -297.17% | -279.82% | -26.59% | -51.25% | -370.18% | -167.28% | 0.22% | -103.23% | -33.50% | 5.15% | 4.00% | 10.06% | 64.98% | |||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -47.89% | -29.00% | -27.73% | -36.72% | -42.84% | -49.85% | -57.46% | -64.34% | -66.33% | -388.46% | -3,250.34% | 556.83% | -388.80% | -20.30% | -27.46% | -238.22% | -113.70% | -77.11% | -1.07% | 15.79% | |||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | -41.20% | -39.53% | -47.19% | -60.08% | -72.31% | -79.34% | -91.46% | -113.33% | -176.19% | -284.78% | -132.47% | -68.19% | -89.06% | -73.16% | -36.00% | -26.48% | -3.39% | -101.09% | |||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -40.71% | -24.48% | -27.09% | -29.97% | -38.50% | -50.01% | -53.47% | -64.19% | -67.69% | -54.99% | -60.42% | -61.11% | -44.34% | -17.76% | -16.08% | -23.69% | -18.15% | -15.25% | -50.28% | -25.64% |